Clinical Trial Update: Real-World Evidence of Adherence to Denosumab Therapy and Fracture Risk Associated With Drug Withdrawal: A Cross-sectional Study

View source ↗

Summary

Real-world evidence assesses adherence to denosumab therapy for osteoporosis and examines fracture risk after withdrawal from treatment. The cross-sectional stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Trakya University | Conditions: Osteoporosis | Status: COMPLETED